
Dr. Chapman from Memorial Sloan-Kettering Cancer Center on Vemurafenib Combination Therapies

Your AI-Trained Oncology Knowledge Connection!


Dr. Chapman from Memorial Sloan-Kettering Cancer Center on Vemurafenib Combination Therapies

Dr. Hoos From Bristol-Myers Squibb Discusses Key Points of the Ipilimumab Trial

Dr. Chapman From Memorial Sloan-Kettering Cancer Center Describes Recent Melanoma Advances

Dr. Virgo From American Cancer Society Shares the Results of the PCP/MO Barriers Study

Dr Kris From Memorial Sloan-Kettering Cancer Center Discusses Methotrexate in Acute Lymphocytic Leukemia

Dr Paz-Ares from Seville University Hospital Discusses Pemetrexed Clinical Trial

Dr. Chapman From Memorial Sloan-Kettering Describes the Vemurafenib Clinical Trial

Dr. Vogelzang from the Comprehensive Cancer Centers of Nevada Discusses Cabozantinib Trial Design

Dr. Infante from Sarah Cannon Research Institute on the Future of BRAF Inhibitors in Melanoma

Dr. Heikki Joensuu from the Helsinki University Central Hospital Discusses the Progress of gastrointestinal stromal tumors (GIST) Treatments

Ruth Rechis from LIVESTRONG on the Key Points of Her Presentation

Dana Monroe from San Francisco Oncology Associates Discusses Ipilimumab's Side Effects

Oncology Nursing Society President Carlton Brown Describes the ONS Social Media Efforts

Karen Hagemaster From Advocate Good Samaritan Hospital on Chemotherapy Documentation Study Results

Carlton Brown President of the Oncology Nursing Society (ONS) Gives His Perspective on the War on Cancer

Colleen OLeary from James Cancer Hospital Describes Chemotherapy Safety Standards

Reynaldo Garcia from the UNC Lineberger Comprehensive Cancer Center Explains the BCR-ABL Study

Reynaldo Garcia from the University of North Carolina Lineberger Comprehensive Cancer Center on BCR-ABL Testing in Chronic Myelogenous Leukemia

Donna Berry from the Phyllis F. Cantor Center at the Dana-Farber Cancer Institute on the Future of Oncology Nursing

Donna Berry from the Phyllis F. Cantor Center at the Dana-Farber Cancer Institute on the Implications of Oral Oncolytics

Kristie Howlett from the Sutter Roseville Medical Center on the Importance of Patient Hand Wiping

Donna Berry from Phyllis F. Cantor Center at the Dana-Farber Cancer Institute on the Symptom Management Excellence Initiative

Janet Hampton from the University of Michigan Health System Cancer Center Explains the Distress Thermometer Study

Janet Hampton University of Michigan Health System Cancer Center Explains Distress Thermometer Study Results

Donna Berry Discusses Her Prostate Cancer Research

Juanita Madison from the Seattle Cancer Care Alliance on Handling the Provenge Treatment Process

Janet Hampton Describes the Distress Thermometer

Juanita Madison from Seattle Cancer Care Alliance Describes the Provenge Treatment Process

Suzanne Beauchene from Seattle Cancer Care Alliance Discusses the Provenge Treatment Process from Start to Finish

Dr. Markman on HPV Testing to Detect Cervical Cancer